XML 55 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Summary of segment performance
The following table reflects adjustments to previously reported costs in our Unallocated segment, that are now allocated to our CAG, Water, LPD and Other segments for the three and six months ended June 30, 2019, respectively:
(in thousands)Three Months Ended June 30, 2019
CAGWaterLPDOtherUnallocated
Cost of sales$344  $15  $19  $ $(386) 
Gross profit(344) (15) (19) (8) 386  
Operating Expenses:
Sales and marketing$(18) $(1) $(1) $—  $20  
General and administrative(893) (179) (206) 949  329  
Research and development3,960  10  13  —  (3,983) 
Total operating expenses3,049  (170) (194) 949  (3,634) 
Income from operations$(3,393) $155  $175  $(957) $4,020  

(in thousands)Six Months Ended June 30, 2019
CAGWaterLPDOtherUnallocated
Cost of sales$162  $ $ $ $(182) 
Gross profit(162) (7) (9) (4) 182  
Operating Expenses:
Sales and marketing$111  $ $ $—  $(122) 
General and administrative(1,095) (219) (253) 1,164  403  
Research and development7,518  19  24  —  (7,561) 
Total operating expenses6,534  (195) (223) 1,164  (7,280) 
Income from operations$(6,696) $188  $214  $(1,168) $7,462  



        
The following is a summary of segment performance:
For the Three Months Ended June 30,
CAGWaterLPDOtherConsolidated Total
2020
Revenue$566,100  $28,116  $32,244  $11,132  $637,592  
Income (loss) from operations$167,969  $12,258  $8,249  $4,772  $193,248  
Interest expense, net(9,426) 
Income before provision for income taxes183,822  
Provision for income taxes34,826  
Net income148,996  
Less: Net income attributable to noncontrolling interest56  
Net income attributable to IDEXX Laboratories, Inc. stockholders$148,940  
2019
Revenue$547,349  $34,764  $33,104  $4,886  $620,103  
Income (loss) from operations$141,190  $16,722  $6,568  $(205) $164,275  
Interest expense, net(8,153) 
Income before provision for income taxes156,122  
Provision for income taxes30,421  
Net income125,701  
Less: Net loss attributable to noncontrolling interest(5) 
Net income attributable to IDEXX Laboratories, Inc. stockholders$125,706  
(in thousands)For the Six Months Ended June 30,
CAGWaterLPDOtherConsolidated Total
2020     
Revenue$1,118,096  $62,265  $66,398  $17,169  $1,263,928  

Income from operations$286,628  $28,140  $17,912  $4,893  $337,573  
Interest expense, net(16,978) 
Income before provision for income taxes320,595  
Provision for income taxes59,743  
Net income260,852  
Less: Net income attributable to noncontrolling interest85  
Net income attributable to IDEXX Laboratories, Inc. stockholders$260,767  

2019
Revenue$1,056,267  $65,074  $64,610  $10,208  $1,196,159  

Income from operations$252,909  $30,537  $12,857  $1,110  $297,413  
Interest expense, net(16,499) 
Income before provision for income taxes280,914  
Provision for income taxes52,504  
Net income228,410  
Less: Net income attributable to noncontrolling interest23  
Net income attributable to IDEXX Laboratories, Inc. stockholders$228,387